Tag: haemorrhagic stroke

EFFECTS trial fluoxetine

Routine use of fluoxetine after acute stroke not recommended

The final results of EFFECTS (Efficacy of fluoxetine: A randomised controlled trial in stroke) have been presented by Erik Lundström (Uppsala University, Uppsala, Sweden)...
COVID-19 in London

Stroke care in London as pressure on NHS rises amid COVID-19

Following the announcement that the UK will remain on lockdown for the foreseeable future, NeuroNews speaks to Shahram Derakhshani about the impact of COVID-19...

ISC News: Blacks, Hispanics of Caribbean descent have higher stroke risk...

Both Blacks and Hispanics of Caribbean descent living in Northern Manhattan have a significantly higher risk of stroke than their non-Hispanic, white neighbours, according...
portable MRI

Portable MRIs bring diagnostics to stroke patients’ bedside

A portable, low-field magnetic resonance imaging (MRI) system may become a safe and practical way to get accurate brain images at a patient’s bedside,...
aidoc AI stroke treatment

US FDA clears Aidoc’s complete AI stroke package

Aidoc has announced that the US Food and Drug Administration (FDA) has cleared its AI solution for flagging large vessel occlusion (LVO) in head...
imperative care financing series C

Imperative Care announces US$85 million Series C financing for stroke treatments

Imperative Care has completed the initial closing of a Series C financing of US$85 million to support the commercial launch of the company’s portfolio,...

Philips extends AI portfolio with launch of IntelliSpace AI Workflow Suite...

Philips announces the launch of IntelliSpace AI Workflow Suite to enable healthcare providers to seamlessly integrate AI applications into the imaging workflow. Part of...
RAPID imaging

RAPID platform expands to address haemorrhagic stroke

iSchemaView has launched the newest addition to the RAPID platform, RAPID ICH at the 2019 Congress of Neurological Surgeons (CNS) Annual Meeting (19–23 October,...
aidoc AI stroke treatment

Aidoc releases complete AI package to speed identification and treatment of...

Aidoc, provider of artificial intelligence (AI) solutions to radiologists, has announced the release of its complete AI package for the identification and triage of...

Overlook Medical Center participates in study evaluating best medical management for...

Overlook Medical Center’s Atlantic Neuroscience Institute is set to participate in the MIND trial: a prospective, multicentre, randomised controlled trial (RCT) examining the Artemis...

Big data set to increase the efficiency of stroke outcomes research

A topical review published in Stroke investigates new approaches for the collection of outcomes data after stroke. In the context of global technological growth,...

First intracranial aneurysm patients treated with BRAVO Flow Diverter

Cerenovus, part of the Johnson & Johnson Medical Devices Companies, has announced that the first patients have been treated with the BRAVO Flow Diverter,...

VITAL study shows promise for early identification of serious strokes

The results of the VITAL study demonstrate that a non-invasive, visor-like neurological device (VIPS technology from Cerebrotech Medical Systems) can identify those patients with...

Cirrhosis associated with increased risk of stroke

Cirrhosis was associated with increased risk of stroke, especially haemorrhagic, in a study that included a representative sample of more than 1.6 million Medicare...

First patient enrolled in haemorrhagic stroke RCT

The first patient has been enrolled in the ENRICH (Early minimally-invasive removal of ICH) randomised clinical trial (RCT). This trial is designed to determine the...

Codman Neuro agrees US distribution of InNeuroCo intermediate catheters

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, has entered into an agreement with InNeuroCo for exclusive US and European distribution...

Data show significant favourable results for NICO BrainPath approach

Two peer-reviewed studies recently published in Neurosurgery and Operative Neurosurgery have shown statistically significant data in favour of the BrainPath approach (NICO), citing more...

NICO announces BrainPath haemorrhagic stroke trial

Two of Atlanta’s stroke centres, associated with Emory University School of Medicine, have joined NICO (Neurosurgical Intervention Company) to perform a randomised controlled trial...